Fig. 1Changes in the incidence of hypoglycaemia in insulin-naïve and prior insulin users after 24 weeks of treatment with insulin detemir ± oral glucose-lowering drugs.

References in context

For people changing insulin to treatment with insulin detemir, significant reductions were also reported in the incidence of overall, minor, and nocturnal events (p<0.0001 for all) (Fig. 1).Go to context

Overall, the proportion of patients reaching HbA1c<7.0% [53 mmol/mol] increased from 3.0% at baseline to 31.5% after 24 weeks; similar results were reported for the pre-study therapy subgroups (Table 2).Go to context

Overall, the proportion of patients reaching HbA1c<7.0% [53 mmol/mol] increased from 3.0% at baseline to 31.5% after 24 weeks; similar results were reported for the pre-study therapy subgroups (Table 2).Go to context